Skip to main content
. 2019 Nov 1;10:1098. doi: 10.3389/fneur.2019.01098

Table 3.

Comparison of NMS between SMAII and SMAIII.

Distribution of response “yes” in percentages Chi-squared-test
SMAII SMAIII for yes–no
Dribbling 7.4 2.3 0.307
Taste/smelling difficulties 0 0 n.c.
Swallowing difficulties 29.6 20.9 0.409
Vomiting 11.1 9.3 0.806
Constipation 11.1 14.0 0.729
Bowel incontinence 0 0 n.c.
Bowel emptying 22.2 16.3 0.534
Urgency 7.4 9.3 0.783
Nocturia 0 2.3 0.425
Pains 11.1 9.3 0.806
Weight loss 7.4 7.0 0.946
Difficulties of remembering 18.5 16.3 0.809
Loss of interest 7.4 9.3 0.783
Hallucinations 0 0 n.c.
Concentration difficulties 22.2 18.6 0.713
Sad, blues 40.7 32.6 0.487
Anxiety 25.9 11.6 0.122
Changes of sex drive 18.5 7.0 0.140
Sex difficulty 7.4 4.7 0.629
Felling dizzy 22.2 11.6 0.236
Falling* 3.7 25.6 0.018
Daytime sleepiness 0 4.7 0.256
Insomnia 25.9 34.9 0.432
Intense vivid dreams 26.0 14.0 0.210
Acting out during dreams* 25.9 7.1 0.031
Restless legs 14.8 25.6 0.285
Swelling legs 37.0 37.2 0.988
Excessive Sweating 14.8 18.6 0.682
Diplopia 0 4.7 0.256
Delusions 0 2.3 0.425

Significantly different items are labeled with

*

p < 0.05; n.c., non-calculable.